Fund HoldingsFairmount Funds Management LLC

Total Portfolio Value
$771.90M
Total Bought
$123.21M
Total Sold
$10.22M
Net Transaction
+$112.99M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
JADE BIOSCIENCES INC03,220,368+3,220,368032,1714.17%+32,171
KINIKSA PHARMACEUTICALS INTL(KNSA)1,102,2481,772,839+670,59124,48149,0546.36%+24,574
CRESCENT BIOPHARMA INC.01,387,866+1,387,866022,4002.90%+22,400
SCHOLAR ROCK HLDG CORP(SRRK)1,374,0311,824,031+450,00044,17564,6078.37%+20,432
APOGEE THERAPEUTICS INC(APGE)2,048,6472,048,647076,53788,97311.53%+12,435
ENLIVEN THERAPEUTICS INC3,202,7983,711,444+508,64663,03174,4529.65%+11,421
CYTOMX THERAPEUTICS INC03,896,582+3,896,58208,8451.15%+8,845
COGENT BIOSCIENCES INC(COGT)6,225,6416,225,641037,29244,7005.79%+7,409
NUVALENT INC727,563727,563051,59955,5137.19%+3,914
ZENAS BIOPHARMA INC(ZBIO)1,892,8061,892,806014,95318,3412.38%+3,388
ORUKA THERAPEUTICS INC(ORKA)3,371,9223,371,922034,59637,7994.90%+3,203
VIRIDIAN THERAPEUTICS INC(VRDN)3,445,8133,459,913+14,10046,45048,3706.27%+1,920
DIANTHUS THERAPEUTICS INC(DNTH)2,700,6912,707,191+6,50048,99150,4356.53%+1,444
ASTRIA THERAPEUTICS INC3,554,1293,554,129018,97919,0502.47%+71
INHIBIKASE THERAPEUTICS INC6,125,0006,125,000013,41411,9441.55%-1,470
SPYRE THERAPEUTICS INC(SYRE)4,018,1014,018,101064,83260,1517.79%-4,681
AXSOME THERAPEUTICS INC(AXSM)815,176815,176095,07485,09611.02%-9,978
BICARA THERAPEUTICS INC784,1700-784,17010,2180-10,218
Page 1 of 1